Walpar Nutritions Ltd

As of 18-Nov, Walpar Nutritions Ltd's stock price is declining at 42.15, down 4.96%, and has underperformed its sector. Despite a recent increase in delivery volume, the stock has a year-to-date decline of 16.53%, contrasting with the broader market's positive performance.

As of November 17, 2025, Walpar Nutrition is considered very attractive and undervalued with a PE ratio of 24.64 and an EV to EBITDA of 14.13, making it a more appealing investment compared to peers like Hindustan Unilever and Nestle India, despite a year-to-date return of -12.18% against the Sensex's 10.02%.

Walpar Nutrition has demonstrated significant growth from Mar'21 to Mar'25, with net sales increasing from 6.07 Cr to 71.76 Cr, and profit after tax rising from 0.15 Cr to 2.80 Cr, reflecting enhanced profitability and shareholder value. Total assets and liabilities have also grown proportionally, indicating a strong financial performance across various metrics.

As of 13-Nov, Walpar Nutritions Ltd is seeing a price increase to 46.65, up 1.63%, and has outperformed its sector today. However, despite strong short-term performance, the stock is down 7.62% year-to-date, indicating challenges in longer-term performance.

As of November 7, 2025, Walpar Nutrition is considered fairly valued with a PE ratio of 24.45, making it a more attractive investment compared to peers like Hindustan Unilever and Nestle India, despite a year-to-date underperformance of -12.87% against the Sensex, while showing a strong long-term return of 54.12% over three years.

As of November 7, 2025, Walpar Nutrition is considered fairly valued with a PE ratio of 24.45 and strong growth prospects, positioning it attractively compared to peers like Hindustan Unilever and Nestle India, despite a recent decline in stock performance.

As of November 7, 2025, Walpar Nutrition is considered fairly valued with a PE ratio of 24.45, significantly lower than its peers Hindustan Unilever and Nestle India, making it an attractive investment despite recent underperformance compared to the Sensex.

As of November 6, 2025, Walpar Nutrition is considered very attractive and undervalued with a PE ratio of 24.45, significantly lower than peers like Hindustan Unilever and Nestle India, and has delivered a strong 54.12% return over the past three years despite underperforming the Sensex year-to-date.

As of November 4, 2025, Walpar Nutrition is fairly valued with a PE ratio of 24.45, lower than its peers Hindustan Unilever and Nestle India, indicating a more attractive investment despite a year-to-date decline of -12.87% compared to the Sensex's 8.26%, while maintaining strong operational efficiency with a ROCE of 18.00% and ROE of 11.26%.

As of November 4, 2025, Walpar Nutrition is considered fairly valued with a PE ratio of 24.45 and strong growth potential, making it a more appealing investment compared to peers like Hindustan Unilever and Nestle India, despite its year-to-date underperformance against the Sensex.

As of October 15, 2025, Walpar Nutrition is considered very attractive and undervalued, with a PE ratio of 24.45, an EV to EBITDA ratio of 14.02, and a PEG ratio of 0.47, significantly outperforming peers like Hindustan Unilever and Nestle India, while also achieving a 4.76% return compared to the Sensex's 1.11%.

As of October 9, 2025, Walpar Nutrition is fairly valued with a PE ratio of 24.50, making it more attractively priced than peers like Hindustan Unilever and Nestle India, despite a year-to-date decline of 12.67% compared to the Sensex's gain of 6.50%, although it has shown strong growth of 47.25% over the past three years.

As of 08-Oct, Walpar Nutritions Ltd's stock price has increased to 42.00, up 2.44%, but it has seen a significant drop in investor participation with a 70.59% decrease in delivery volume. Despite a short-term gain of +5.79% over the past week, the stock has a year-to-date decline of -16.83%, underperforming compared to the Sensex's gain of +5.93%.

As of 24-Sep, Walpar Nutritions Ltd's stock price is Rs. 39.95, down 0.87%, and has reached a 52-week low of Rs. 38.3. The stock has significantly underperformed, with a 13.81% drop in the past month and a 20.89% decline year-to-date, despite a recent increase in delivery volume.

As of 23-Sep, Walpar Nutritions Ltd's stock price is Rs. 40.30, down 0.49%, and has reached a 52-week low of Rs. 38.55. Despite a slight short-term outperformance against the Sensex, the stock has declined 20.20% year-to-date, indicating negative overall sentiment and reduced investor participation.

As of 22-Sep, Walpar Nutritions Ltd is priced at 40.50 with no change in its stock price. Despite a recent short-term uptick, the stock has declined significantly over the past month and year-to-date, underperforming the benchmark Sensex.

As of 19-Sep, Walpar Nutritions Ltd's stock price is at 40.50, down 0.12%, with significant underperformance over various periods and reduced investor interest. Despite outperforming its sector today, it remains below moving averages and contrasts sharply with the benchmark Sensex, which has gained 7.11% year-to-date.

As of 18-Sep, Walpar Nutritions Ltd is priced at 40.55, having increased by 1.37% today but down 19.70% year-to-date. Despite a bearish trend and trading below moving averages, increased investor participation indicates growing interest.

As of 17-Sep, Walpar Nutritions Ltd is priced at Rs 40.00, with a significant decline of 11.50% over the past week and 20.79% year-to-date, underperforming against the benchmark Sensex, which has gained 1.43%. The stock is near its 52-week low and trading below all moving averages, indicating weak investor confidence.